Uniform Formulary Beneficiary Advisory Panel; Notice of Federal Advisory Committee Meeting, 26992-26993 [2018-12445]
Download as PDF
<![CDATA[
daltland on DSKBBV9HB2PROD with NOTICES
26992
Federal Register / Vol. 83, No. 112 / Monday, June 11, 2018 / Notices
Effective Teams, Class of 2022 Profile,
SHARP (Sexual Harassment Assault
Response and Prevention) Program,
Intellectual Capital and Outreach,
Stewardship, USMA 2035, Culture of
Excellence, Highlights from Academic
Year 2018.
Public’s Accessibility to the Meeting:
Pursuant to 5 U.S.C. 552b and 41 CFR
102–3.140 through 102–3.165 and
subject to the availability of space, this
meeting is open to the public. Seating is
on a first to arrive basis. Attendees are
requested to submit their name,
affiliation, and daytime phone number
seven business days prior to the meeting
to Mrs. Ghostlaw, via electronic mail,
the preferred mode of submission, at the
address listed in the FOR FURTHER
INFORMATION CONTACT section. Pursuant
to 41 CFR 102–3.140d, the committee is
not obligated to allow a member of the
public to speak or otherwise address the
committee during the meeting, and
members of the public attending the
committee meeting will not be
permitted to present questions from the
floor or speak to any issue under
consideration by the committee.
Because the committee meeting will be
held in a Federal Government facility on
a military post, security screening is
required. A government photo ID is
required to enter post. In order to enter
the installation, members of the public
must first go to the Visitor Control
Center in the Visitor Center and go
through a background check before
being allowed access to the installation.
Members of the public then need to park
in Buffalo Soldier Field parking lot and
ride the Central Post Area (CPA) shuttle
bus to the meeting location. Please note
that all vehicles and persons entering
the installation are subject to search
and/or an identification check. Any
person or vehicle refusing to be
searched will be denied access to the
installation. Members of the public
should allow at least an hour for
security checks and the shuttle ride. The
United States Military Academy,
Jefferson Hall, is fully handicap
accessible. Wheelchair access is
available at the south entrance of the
building. For additional information
about public access procedures, contact
Mrs. Ghostlaw, the committee’s
Designated Federal Officer, at the email
address or telephone number listed in
the FOR FURTHER INFORMATION CONTACT
section.
Written Comments or Statements:
Pursuant to 41 CFR 102–3.105(j) and
102–3.140 and section 10(a)(3) of the
Federal Advisory Committee Act, the
public or interested organizations may
submit written comments or statements
to the committee, in response to the
VerDate Sep<11>2014
19:19 Jun 08, 2018
Jkt 244001
stated agenda of the open meeting or in
regard to the committee’s mission in
general. Written comments or
statements should be submitted to Mrs.
Ghostlaw, the committee Designated
Federal Officer, via electronic mail, the
preferred mode of submission, at the
address listed in the FOR FURTHER
INFORMATION CONTACT section. Each page
of the comment or statement must
include the author’s name, title or
affiliation, address, and daytime phone
number. Written comments or
statements should be submitted to Mrs.
Ghostlaw, the committee Designated
Federal Officer, via electronic mail, the
preferred mode of submission, at the
address listed in the FOR FURTHER
INFORMATION CONTACT section. Written
comments or statements being
submitted in response to the agenda set
forth in this notice must be received by
the Designated Federal Official at least
seven business days prior to the meeting
to be considered by the committee. The
Designated Federal Official will review
all timely submitted written comments
or statements with the committee
Chairperson and ensure the comments
are provided to all members of the
committee before the meeting. Written
comments or statements received after
this date may not be provided to the
committee until its next meeting.
Pursuant to 41 CFR 102–3.140d, the
committee is not obligated to allow a
member of the public to speak or
otherwise address the committee during
the meeting. However, the committee
Designated Federal Official and
Chairperson may choose to invite
certain submitters to present their
comments verbally during the open
portion of this meeting or at a future
meeting. The Designated Federal
Officer, in consultation with the
committee Chairperson, may allot a
specific amount of time for submitters to
present their comments verbally.
Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2018–12501 Filed 6–8–18; 8:45 am]
BILLING CODE 5001–03–P
DEPARTMENT OF DEFENSE
Office of the Secretary
Uniform Formulary Beneficiary
Advisory Panel; Notice of Federal
Advisory Committee Meeting
Under Secretary of Defense for
Personnel and Readiness, Department of
Defense.
ACTION: Notice of Federal Advisory
Committee meeting.
AGENCY:
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
The Department of Defense
(DoD) is publishing this notice to
announce that the following Federal
Advisory Committee meeting of the
Uniform Formulary Beneficiary
Advisory Panel will take place.
DATES: Open to the Public Thursday,
July 12, 2018, from 9:00 a.m. to 12:00
p.m.
SUMMARY:
The address of the open
meeting is the Naval Heritage Center
Theater, 701 Pennsylvania Avenue NW,
Washington, DC 20004.
FOR FURTHER INFORMATION CONTACT: Col
Paul J. Hoerner, U.S. Air Force, 703–
681–2890 (Voice), None (Facsimile),
dha.ncr.health-it.mbx.baprequests@
mail.mil (Email). Mailing address is
7700 Arlington Boulevard, Suite 5101,
Falls Church, VA 22042–5101. Website:
https://www.health.mil/About-MHS/
Other-MHS-Organizations/BeneficiaryAdvisory-Panel. The most up-to-date
changes to the meeting agenda can be
found on the website.
SUPPLEMENTARY INFORMATION: This
meeting is being held under the
provisions of the Federal Advisory
Committee Act (FACA) of 1972 (5
U.S.C., Appendix, as amended), the
Government in the Sunshine Act of
1976 (5 U.S.C. 552b, as amended), and
41 CFR 102–3.140 and 102–3.150.
Purpose of Meeting: The Panel will
review and comment on
recommendations made to the Director
of the Defense Health Agency, by the
Pharmacy and Therapeutics Committee,
regarding the Uniform Formulary.
Purpose of the Meeting: The
Department of Defense is publishing
this notice to announce a Federal
Advisory Committee meeting of the
Uniform Formulary Beneficiary
Advisory Panel (hereafter referred to as
the Panel) will take place.
ADDRESSES:
Agenda
1. Sign-In
2. Welcome and Opening Remarks
3. Scheduled Therapeutic Class Reviews
(Comments will follow each agenda
item)
a. Gastrointestinal-2 Miscellaneous
Agents—Opioid-Induced
Constipation Subclass
b. Growth Stimulating Agents
c. Pancreatic Enzyme Replacement
Therapy Agents
4. Newly Approved Drugs Review
5. Pertinent Utilization Management
Issues 6. Panel Discussions and
Vote
Meeting Accessibility: Meeting
Accessibility: Pursuant to 5 U.S.C. 552b,
as amended, and 41 Code of Federal
Regulations (CFR) 102–3.140 through
E:\FR\FM\11JNN1.SGM
11JNN1
Federal Register / Vol. 83, No. 112 / Monday, June 11, 2018 / Notices
102–3.165, and the availability of space,
this meeting is open to the public.
Seating is limited and will be provided
only to the first 220 people signing-in.
All persons must sign-in legibly.
Written Statements: Written
Statements: Pursuant to 41 CFR 102–
3.140, the public or interested
organizations may submit written
statements to the membership of the
Panel about its mission and/or the
agenda to be addressed in this public
meeting. Written statements should be
submitted to the Panel’s Designated
Federal Officer (DFO).The DFO’s
contact information can be obtained
previously in this announcement.
Written comments or statements must
be received by the committee DFO at
least five (5) business days prior to the
meeting so that they may be made
available to the Panel for its
consideration prior to the meeting. The
DFO will review all submitted written
statements and provide copies to all the
committee members.
Dated: June 6, 2018.
Shelly E. Finke,
Alternate OSD Federal Register Liaison
Officer, Department of Defense.
[FR Doc. 2018–12445 Filed 6–8–18; 8:45 am]
BILLING CODE 5001–06–P
DEPARTMENT OF DEFENSE
Office of the Secretary
Charter Renewal of Department of
Defense Federal Advisory Committees
Department of Defense.
ACTION: Renewal of Federal Advisory
Committee.
AGENCY:
The Department of Defense
(DoD) is publishing this notice to
announce that it is renewing the charter
for the National Intelligence University
Board of Visitors (‘‘the Board’’).
FOR FURTHER INFORMATION CONTACT: Jim
Freeman, Advisory Committee
Management Officer for the Department
of Defense, 703–692–5952.
SUPPLEMENTARY INFORMATION: The
Board’s charter is being renewed in
accordance with the Federal Advisory
Committee Act (FACA) of 1972 (5
U.S.C., Appendix, as amended) and 41
CFR 102–3.50(d). The Board’s charter
and contact information for the Board’s
Designated Federal Officer (DFO) can be
found at https://www.facadatabase.gov/.
The Board provides the Secretary of
Defense and the Deputy Secretary of
Defense, through the Under Secretary of
Defense for Intelligence (USD(I)) and the
Director, Defense Intelligence Agency,
independent advice and
daltland on DSKBBV9HB2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
19:19 Jun 08, 2018
Jkt 244001
recommendations on matters related to
the mission, policy, accreditation,
faculty, students, facilities, curricula,
educational methods, research, and
administration of the National
Intelligence University.
The Board is composed of no more
than 12 members who have extensive
professional experience in the fields of
national intelligence, national defense,
and academia. The following ex-officio
positions shall also serve on the Board:
The Under Secretary for Intelligence
and Analysis, U.S. Department of
Homeland Security; the Assistant
Director of National Intelligence for
Human Capital and Chief Human
Capital Officer for the Intelligence
Community, DoD Office of the Director
of National Intelligence, and; the Deputy
Executive Director of management and
Learning, Central Intelligence Agency
and Chief Learning Officer, Central
Intelligence Agency University. All
members of the Board are appointed to
provide advice on behalf of the
Government on the basis of their best
judgment without representing any
particular point of view and in a manner
that is free from conflict of interest.
Except for reimbursement of official
Board -related travel and per diem,
Board members serve without
compensation.
The public or interested organizations
may submit written statements to the
Board membership about the Board’s
mission and functions. Written
statements may be submitted at any
time or in response to the stated agenda
of planned meeting of the Board. All
written statements shall be submitted to
the DFO for the Board, and this
individual will ensure that the written
statements are provided to the
membership for their consideration.
Dated: June 5, 2018.
Shelly E. Finke,
Alternate OSD Federal Register Liaison
Officer, Department of Defense.
[FR Doc. 2018–12439 Filed 6–8–18; 8:45 am]
BILLING CODE 5001–06–P
DEPARTMENT OF DEFENSE
Department of the Navy
Notice of Availability of GovernmentOwned Inventions; Available for
Licensing
Department of the Navy, DoD.
Notice.
AGENCY:
ACTION:
The Department of the Navy
(DoN) announces the availability of the
inventions listed below, assigned to the
United States Government, as
SUMMARY:
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
26993
represented by the Secretary of the
Navy, for domestic and foreign licensing
by the Department of the Navy.
ADDRESSES: Requests for copies of the
patent applications cited should be
directed to Naval Surface Warfare
Center, Crane Div., Code OOL, Bldg. 2,
300 Highway 361, Crane, IN 47522–
5001.
FOR FURTHER INFORMATION CONTACT: Mr.
Christopher Monsey, Naval Surface
Warfare Center, Crane Div., Code OOL,
Bldg. 2, 300 Highway 361, Crane, IN
47522–5001, Email
Christopher.Monsey@navy.mil, 812–
854–2777.
SUPPLEMENTARY INFORMATION: The
following patent application is available
for licensing: Patent Application No. 14/
953,315 (Navy Case No. 200226):
Optimized Subsonic Projectiles and
Related Methods.
Authority: 35 U.S.C. 207, 37 CFR part 404.
Dated: June 5, 2018.
E.K. Baldini,
Lieutenant Commander, Judge Advocate
General’s Corps, U.S. Navy, Federal Register
Liaison Officer.
[FR Doc. 2018–12522 Filed 6–8–18; 8:45 am]
BILLING CODE 3810–FF–P
DEPARTMENT OF ENERGY
Federal Energy Regulatory
Commission
Combined Notice of Filings #1
Take notice that the Commission
received the following electric rate
filings:
Docket Numbers: ER10–1276–008;
ER10–1287–007; ER10–1292–007;
ER10–1303–007; ER10–1319–009;
ER10–1353–009.
Applicants: Consumers Energy
Company, CMS Energy Resource
Management Company, Grayling
Generating Station Limited Partnership,
Genesee Power Station Limited
Partnership, CMS Generation Michigan
Power, LLC, Dearborn Industrial
Generation, L.L.C.
Description: Notice of Non-Material
Change-In-Status of Consumer Energy
Company, et. al.
Filed Date: 5/31/18.
Accession Number: 20180531–5437.
Comments Due: 5 p.m. ET 6/21/18.
Docket Numbers: ER18–1731–000.
Applicants: Midcontinent
Independent System Operator, Inc.
Description: § 205(d) Rate Filing:
2018–06–01_Filing of MISO TOs for
Cost Recovery of Operating and
Maintenance Exp to be effective 8/1/
2018.
E:\FR\FM\11JNN1.SGM
11JNN1
]]>Agencies
[Federal Register Volume 83, Number 112 (Monday, June 11, 2018)]
[Notices]
[Pages 26992-26993]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-12445]
-----------------------------------------------------------------------
DEPARTMENT OF DEFENSE
Office of the Secretary
Uniform Formulary Beneficiary Advisory Panel; Notice of Federal
Advisory Committee Meeting
AGENCY: Under Secretary of Defense for Personnel and Readiness,
Department of Defense.
ACTION: Notice of Federal Advisory Committee meeting.
-----------------------------------------------------------------------
SUMMARY: The Department of Defense (DoD) is publishing this notice to
announce that the following Federal Advisory Committee meeting of the
Uniform Formulary Beneficiary Advisory Panel will take place.
DATES: Open to the Public Thursday, July 12, 2018, from 9:00 a.m. to
12:00 p.m.
ADDRESSES: The address of the open meeting is the Naval Heritage Center
Theater, 701 Pennsylvania Avenue NW, Washington, DC 20004.
FOR FURTHER INFORMATION CONTACT: Col Paul J. Hoerner, U.S. Air Force,
703-681-2890 (Voice), None (Facsimile), [email protected] (Email). Mailing address is 7700 Arlington
Boulevard, Suite 5101, Falls Church, VA 22042-5101. Website: https://www.health.mil/About-MHS/Other-MHS-Organizations/Beneficiary-Advisory-Panel. The most up-to-date changes to the meeting agenda can be found
on the website.
SUPPLEMENTARY INFORMATION: This meeting is being held under the
provisions of the Federal Advisory Committee Act (FACA) of 1972 (5
U.S.C., Appendix, as amended), the Government in the Sunshine Act of
1976 (5 U.S.C. 552b, as amended), and 41 CFR 102-3.140 and 102-3.150.
Purpose of Meeting: The Panel will review and comment on
recommendations made to the Director of the Defense Health Agency, by
the Pharmacy and Therapeutics Committee, regarding the Uniform
Formulary.
Purpose of the Meeting: The Department of Defense is publishing
this notice to announce a Federal Advisory Committee meeting of the
Uniform Formulary Beneficiary Advisory Panel (hereafter referred to as
the Panel) will take place.
Agenda
1. Sign-In
2. Welcome and Opening Remarks
3. Scheduled Therapeutic Class Reviews (Comments will follow each
agenda item)
a. Gastrointestinal-2 Miscellaneous Agents--Opioid-Induced
Constipation Subclass
b. Growth Stimulating Agents
c. Pancreatic Enzyme Replacement Therapy Agents
4. Newly Approved Drugs Review
5. Pertinent Utilization Management Issues 6. Panel Discussions and
Vote
Meeting Accessibility: Meeting Accessibility: Pursuant to 5 U.S.C.
552b, as amended, and 41 Code of Federal Regulations (CFR) 102-3.140
through
[[Page 26993]]
102-3.165, and the availability of space, this meeting is open to the
public. Seating is limited and will be provided only to the first 220
people signing-in. All persons must sign-in legibly.
Written Statements: Written Statements: Pursuant to 41 CFR 102-
3.140, the public or interested organizations may submit written
statements to the membership of the Panel about its mission and/or the
agenda to be addressed in this public meeting. Written statements
should be submitted to the Panel's Designated Federal Officer (DFO).The
DFO's contact information can be obtained previously in this
announcement. Written comments or statements must be received by the
committee DFO at least five (5) business days prior to the meeting so
that they may be made available to the Panel for its consideration
prior to the meeting. The DFO will review all submitted written
statements and provide copies to all the committee members.
Dated: June 6, 2018.
Shelly E. Finke,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2018-12445 Filed 6-8-18; 8:45 am]
BILLING CODE 5001-06-P
